Published Paper Details:

Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common chronic liver disorders worldwide and is emerging as a serious metabolic health burden. It is characterized by excessive fat accumulation in hepatocytes in individuals with negligible alcohol intake. The increasing prevalence of obesity, diabetes mellitus, dyslipidemia, sedentary lifestyle, and metabolic syndrome has significantly contributed to the rise of NAFLD globally. Modern medical science currently emphasizes lifestyle modification as the primary therapeutic intervention, while no universally accepted pharmacological treatment is available. Ayurveda explains liver disorders under the concepts of Yakrit Roga, Medoroga, Santarpanottha Vikara, and Agnimandya.1 Arogyavardhini Vati is a classical Kharaliya Rasayana formulation extensively used in hepatic, metabolic, dermatological, and digestive disorders. The formulation contains Katuki, Triphala, Guggulu, Shilajatu, Tamra Bhasma, Loha Bhasma, and purified mineral ingredients possessing Deepana, Pachana, Lekhana, Medohara, and hepatoprotective properties.2 The formulation acts by correcting impaired Agni, eliminating Ama, stimulating bile secretion, improving lipid metabolism, and protecting hepatocytes from oxidative stress and inflammation. Several clinical and experimental studies have demonstrated the efficacy of Arogyavardhini Vati in improving liver enzymes, lipid profile, hepatomegaly, and ultrasonographic findings in NAFLD patients.3 This review critically evaluates the role of Arogyavardhini Vati in NAFLD from both Ayurvedic and modern perspectives.